Variant : CV192127 (NM_013382.5(POMT2):c.1903G>A (p.Val635Ile)) Homo sapiens |
Symbol: |
CV192127 |
Name: |
NM_013382.5(POMT2):c.1903G>A (p.Val635Ile) |
RGD ID: |
10050573 |
Condition: |
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2 [RCV000543953]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 [RCV000763950]|not provided [RCV000712836]|not specified [RCV000175458] |
Clinical Significance: |
conflicting interpretations of pathogenicity|uncertain significance |
Last Evaluated: |
05/07/2019 |
Review Status: |
criteria provided, conflicting interpretations|criteria provided, multiple submitters, no conflicts|criteria provided, single submitter |
Related Genes: |
POMT2 |
Variant Type: |
single nucleotide variant
(SO:0001583)
|
Source: |
CLINVAR |
Molecular Consequence: |
missense variant |
Evidence: |
clinical testing |
HGVS Name(s): |
NM_013382.5:c.1903G>A
NG_008897.1:g.47025G>A
NC_000014.9:g.77278858C>T
NC_000014.8:g.77745201C>T
NP_037514.2:p.Val635Ile
LRG_844t1:c.1903G>A
LRG_844:g.47025G>A
LRG_844p1:p.Val635Ile
|
Position |
Human Assembly | Chr | Position (strand) | Source |
---|
GRCh38 | 14 | 77,278,858 - 77,278,858 | CLINVAR | GRCh37 | 14 | 77,745,201 - 77,745,201 | CLINVAR | Cytogenetic Map | 14 | 14q24.3 | CLINVAR |
|
Trait Synonyms: |
AllHighlyPenetrant; Cerebroocular dysgenesis; Cerebroocular dysplasia muscular dystrophy syndrome; Chemke syndrome; COD-MD syndrome; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2; Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2; Hard +/- E syndrome; Hydrocephalus, agyria and retinal dysplasia; Limb-girdle muscular dystrophy-dystroglycanopathy, type C2; MUSCULAR DYSTROPHY, CONGENITAL, POMT2-RELATED; MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 14; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMT2-RELATED; Pagon syndrome; WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED; WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED; Warburg syndrome |
|